(Extracted from Caduceus 102)
The Government of Shanghai has announced its official recommendation that COVID-19 should be treated with high amounts of intravenous (IV) vitamin C. Dosage recommendations vary with severity of illness, from 50 to 200 milligrams per kilogram body weight per day, to as much as 200 mg/kg/day.
These dosages are approximately 4,000 to 16,000 mg for an adult, administered by IV. This specific method of administration is important, says IV therapy expert, Dr Atsuo Yanagisawa, because vitamin C’s effect is at least 10 times more powerful by IV than if taken orally. President of the Tokyo-based, Japanese College of Intravenous Therapy, Dr Yanagisawa says, ‘Intravenous vitamin C is a safe, effective and broad-spectrum antiviral.’
This comes after the launch of at least three trials of high-dose, IV vitamin C in China and the arrival of 50 tonnes of vitamin C in Wuhan on 22 nd February (photo). This and other details were first released by the news service of the Journal of Orthomolecular Medicine, edited by Dr Andrew Saul ( www.doctoryourself.com) with some 40 doctors worldwide on its editorial board, and based in Wichita, Kansas, USA, managed by the Riordan Clinic there, named after a leading vitamin C pioneer ( www.orthomolecular.org).
High-dose IV vitamin C in China and Korea
A verified, official statement from China’s Xi’an Jiaotong University Second Hospital states:
‘On the afternoon of February 20, 2020, another 4 patients with severe coronavirus pneumonia recovered from the C10 West Ward of Tongji Hospital. In the past 8 patients have been discharged from hospital. . . [H]igh-dose vitamin C achieved good results in clinical applications. We believe that for patients with severe neonatal pneumonia, and for critically ill patients, vitamin C treatment should be initiated as soon as possible after admission. Numerous studies have shown that the dose of vitamin C has a lot to do with the effect of treatment. High-dose vitamin C can not only improve antiviral levels, but more importantly, can prevent and treat acute lung injury (ALI) and acute respiratory distress (ARDS).’
Dr Hyoungjoo Shin in Korea reports:
‘At my hospital in Daegu, South Korea, all inpatients and all staff members have been using vitamin C orally since last week. Some people this week had a mild fever, headaches and coughs, and those who had symptoms got 30,000 mg intravenous vitamin C. Some people got better after about two days, and most had symptoms go away after one injection.’
News of high-dose vitamin C benefits being actively suppressed
However, in certain parts of the media, especially on various online platforms, anyone claiming that vitamin therapy can combat or treat coronavirus is already being labelled as ‘promoting false information’ and promulgating ‘fake news’. Even the sharing of verifiable news, and direct quotes from qualified medical professionals, is being restricted or blocked on social media.
In fact the World Health Organization (WHO) has met with Google and Facebook and other media giants to stop the spread of what they declare to be wrong information: https://tinyurl.com/rx8vps7. Thus, there appears to be concerted attempts to marginalise or discredit the use of vitamin C either orally or in high doses, as used in hospital-based administration of IV vitamin C, despite the fact that it is now being carried out in China.
Ironically, Facebook, blocking any significant users’ sharing of the news of approved vitamin therapy research, is itself blocked in China by the Chinese Government. As for the Internet, it is censored in China but, significantly, the Chinese Government has not blocked this real news on how IV vitamin C can save lives in the COVID-19 epidemic.
Use by European and US doctors
Western doctors have also had success using IV vitamin C to treat acute respiratory distress syndrome (ARDS). In 2017, in the World Journal of Critical Care Medicine, doctors at a Virginia hospital in the US reported the successful treatment, using high-dose IV vitamin C, of a 20-year-old woman, who contracted respiratory enterovirus/rhinovirus infection that led to acute lung injury and rapidly to acute respiratory distress syndrome (ARDS). They state:
‘Infusing high dose intravenous vitamin C into this patient with virus-induced ARDS was associated with rapid resolution of lung injury with no evidence of post-ARDS fibroproliferative sequelae. Intravenous vitamin C as a treatment for ARDS may open a new era of therapy for ARDS from many causes.’
Reference: Fowler III AA et al. Intravenous vitamin C as adjunctive therapy for enterovirus/rhinovirus induced acute respiratory distress syndrome. World Journal of Critical Care Medicine. 2017;6(1):85-90.
A British private practice GP, with decades of experience using high-dose vitamin C, Dr Sarah Myhill, based in Wales, said: ‘You can only fail by under-dosing. Vitamin C is completely safe. The Chinese are on the right track. See her 5-min video on her protocol for using high-dose vitamin C and iodine: https://youtu.be/mSt8GZ6cOl0 and her site: www.drmyhill.co.uk .
JUST PUBLISHED in Medicine in Drug Recovery: Can early and high intravenous dose of vitamin C prevent and treat coronavirus disease 2019 (COVID-19)?by Dr Richard Cheng
NEW, complete, US National Institutes of Health-sponsored presentation by Dr Richard Cheng specifically on research and protocol using vitamin C to prevent and treat COVID-19: http://www.doctoryourself.com/NIH VC in the Prevention and Treatment of Covid-19.pptx